SecBot SecBot
PRESS-RELEASE ·Filed Mar 27, 2026

POCI

Precision Optics Corporation
NEUTRAL
Impact 5/10
Horizonimmediate Processed7mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight • Neutral

Monitor for potential short-term dilution impact on share price; however, the insider participation and oversubscription suggest confidence from existing stakeholders. Watch for future disclosures on cash deployment efficiency.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
POCI ▲ +22.67% at T+60d
NEUTRAL call +22.67% · α vs SPY +6.61% · entry $4.19 → $5.14
Entry = T+0 close
Mar 27, 2026
via day close
T+1d
+0.24%
call +0.24% · α +0.60%
$4.20
settled 7mo ago
T+5d
-4.53%
call -4.53% · α -8.40%
$4.00
settled 7mo ago
T+20d
0.00%
call 0.00% · α -12.74%
$4.19
settled 6mo ago
T+60d
+22.67%
call +22.67% · α +6.61%
$5.14
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Precision Optics Corporation (POCI) announced the pricing of an underwritten public offering of 2,777,777 shares at $3.60 per share, raising approximately $10 million in gross proceeds. The offering is oversubscribed and includes participation from company insiders, with a 45-day option for the underwriter to purchase up to an additional 416,667 shares. Proceeds will be used for working capital and general corporate purposes.

Key Financial Metrics

Deal Value
$10.0M

Key Facts

  • Precision Optics is offering 2,777,777 shares at $3.60 per share, raising ~$10M in gross proceeds.
  • The offering is oversubscribed and includes insider participation from CEO, CFO, and COO.
  • Underwriter has a 45-day option to purchase up to an additional 416,667 shares.
  • Net proceeds will be used for working capital and general corporate purposes.
  • Lucid Capital Markets is the sole book-running manager; closing expected March 30, 2026.

Financial Impact

$10 million gross proceeds (2,777,777 shares × $3.60), potentially up to $11.5 million if overallotment is exercised.

dilutioncashequity

Risk Factors

  • Dilution to existing shareholders if the full offering closes, including overallotment.
  • No specific growth initiatives or strategic uses of capital disclosed, limiting upside catalysts.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3263697
7 reports for POCI
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for POCI — sortable, filterable
TypeNow
Sep 28, 2026
28d ago
Press Release
MIXED ★ 5/10
$4.27awaiting T+60—$4.38 (+2.58%)
Sep 23, 2026
4w ago
Press Release
NEUTRAL ★ 1/10
$4.78awaiting T+60—$4.38 (−8.27%)
May 13, 2026
23w ago
Press Release
BULLISH ★ 7/10
$4.78 $4.24▼ −11.30%▼ −14.89%$4.38 (−8.37%)
Mar 30, 2026
30w ago
Insider Cluster
BULLISH ★ 7/10
$4.20 $5.09▲ +21.19%▲ +4.70%$4.38 (+4.29%)
Mar 27, 2026
30w ago
Press Release
NEUTRAL ★ 5/10
$4.19 $5.14▲ +22.67%▲ +6.61%$4.38 (+4.53%)
Mar 26, 2026
30w ago
424B5
NEUTRAL ★ 4/10
$4.19 $5.14▲ +22.67%▲ +6.61%$4.38 (+4.53%)
Mar 26, 2026
30w ago
Press Release
NEUTRAL ★ 4/10
$4.19 $5.14▲ +22.67%▲ +6.61%$4.38 (+4.53%)
Showing 7 of 7

US Market Status

Market Open — Closes in 2h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 27, 2026